Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 pre-exposure prophylaxis with Truvada and hydroxychloroquine in healthcare personnel
2020-001385-11Phase 3Completed
- Sponsor
- Plan Nacional sobre el Sida
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of emtricitabine + tenofovir disoproxil and hydroxychloroquine in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Plan Nacional sobre el Sida. Primary endpoint: Number of symptomatic confirmed SARS-CoV-2 infections. Started Apr 2020; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxilhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001385-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001385-11.